Advertisement

Advertisement

HotelsFoodShoppingCoffeeGroceryGas

Hydra Biosciences Inc

+1 (617) 494-5230
Website

Advertisement

Advertisement

45 Moulton St
Cambridge, MA 02138
+1 (617) 494-5230
http://hydrabiosciences.com
Hydra Biosciences is a privately held biopharmaceutical company. It has a staff of trained and certified professionals, including advisors, investors, executive officers and financers. The company conducts drug discovery programs that focuses on channels implicated in pain and inflammation diseases. Hydra Biosciences offers medicines for cell-based therapies for organ and tissue restoration. The company s group of investors includes Abingworth Ventures, Advanced Technology Ventures, Polaris Ventures, Lilly Bio Ventures, New Enterprise Associates, BioVentures Investors, Biogen Idec and Boston Medical Investors. It also focuses on therapeutic areas, such as cardiovascular and pulmonary diseases. Hydra Biosciences is located in Cambridge, Mass.
Own this business?
Claim it
See a problem?

You might also like

Drugs and drug proprietaries, Drugs affecting neoplasms and endrocrine systems, Surgical instruments and apparatus

Shire PLC

Shire Specialty Pharmaceuticals is a division of Shire, which offers products under the VYVANSE, DAYTRANA, ADDERALL, FOSRENOL, AGRYLIN, ELAPRASE and PENTASA brand names for the treatment attention deficit hyperactivity disorder. The division sells its products to several pharmaceutical wholesale distributors and pharmacies in the United States and Europe. Founded in 1994, Shire is one of the leading specialty biopharmaceutical companies that focuses on meeting the needs of specialist physicians in Pennsylvania. The parent company has a staff of more than 1,600 employees. Shire s subsidiaries include Shire Human Genetic Therapies UK Limited, Shire Human Genetic Therapies Securities Corporation, Shire Investments & Finance (U.K.) Company, Shire Pharmaceutical Contracts Limited and Shire Intellectual Property 2 SRL.
Drugs acting on the respiratory system, Blood derivatives, Real estate managers

C4T Securities Corporation

C4 Therapeutics, Inc. is a biotechnology company based in Watertown, MA, specializing in targeted protein degradation. Their innovative approach, known as Targeted Protein Degradation (TPD), aims to develop a new generation of medicines for treating various diseases. Through their TORPEDO platform and focus on target selection, C4 Therapeutics is dedicated to transforming lives by degrading disease-causing proteins. With a strong leadership team, board of directors, and scientific advisory board, C4 Therapeutics is committed to advancing their pipeline of therapies, including CFT7455, CFT1946, and CFT8919. They also collaborate with industry partners such as Roche, Biogen, Betta Merck, and others to further their research and development efforts. At C4 Therapeutics, their values, people, and dedication to scientific progress drive their mission to revolutionize the treatment of diseases through targeted protein degradation.Generated from the website
Drugs and drug proprietaries, Commercial research laboratory, Business services, nec, nec

Millennium Pharmaceuticals

Formerly known as Millennium Pharmaceuticals
United States›Massachusetts›Cambridge›Hydra Biosciences Inc

Partial Data by Infogroup (c) 2024. All rights reserved.

Partial Data by Foursquare.

Advertisement

Advertisement

  • Get directions
  • MapQuest Travel
  • Route Planner
  • Print your map
  • Get help
  • Search the web
  • Send feedback
Learn more about our mobile apps.
  • Android app Google Play
  • Download on the App Store
  • Download on the Amazon Appstore
  • Enterprise solutions
  • Claim your business
  • Developer resources
  • Jobs
  • Advertise with us
  • Terms of use
  • Privacy policy
  • Data and licenses
  • About our ads
  • Do not sell